Skip to main content

Homepage

Latest News

Scientists discover a highly potent antibody against SARS-CoV-2

Researchers involved in the CARE project have isolated a highly potent monoclonal antibody against SARS-CoV-2, one of the most powerful identified so far

/news-events/newsroom/scientists-discover-highly-potent-antibody-against-sars-cov-2
/news-events/newsroom/scientists-discover-highly-potent-antibody-against-sars-cov-2

Surge vaccine production principles now written into EU law

Surge vaccine production principles now written into EU law  more

Vaccine trials for hospital superbugs need a radical rethink

Vaccine trials for hospital superbugs need a radical rethink  more

Publications from IMI projects are cited at twice the global average rate

Publications from IMI projects are cited at twice the global average rate  more

 

 

IMI – radical collaboration in action

A new brochure, 'IMI - radical collaboration in action', showcases some recent IMI project successes, which include an approved vaccine for Ebola, insights into the genetics of Alzheimer’s disease, a new classification of diabetes, and advances on using liquid biopsies for cancer, as well as contributions to the fight against COVID-19.

 more

dna.jpg

 

 

 

IMI covid-19 response

 

Within weeks of the first reports of coronavirus in Europe, IMI launched a fast-track Call for proposals to develop therapeutics and diagnostics for current and future coronavirus outbreaks